Loading…
Loading…
VTYX (Ventyx Biosciences, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

| ABSI | Absci Corporation | $8.82 | $1.5B |
| KALV | KalVista Pharmaceuticals, Inc. | $27.00 | $1.4B |
| MLTX | MoonLake Immunotherapeutics | $15.01 | $1.3B |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.39 | $1.2B |
| OLMA | Olema Pharmaceuticals, Inc. | $10.75 | $939.0M |
| RIGL | Rigel Pharmaceuticals, Inc. | $48.67 | $900.5M |
| VSTM | Verastem, Inc. | $8.20 | $720.6M |
| PRTA | Prothena Corporation plc | $9.82 | $514.1M |
| RGNX | REGENXBIO Inc. | $8.94 | $462.2M |
| GOSS | Gossamer Bio, Inc. | $0.18 | $85.7M |